BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10536296)

  • 1. A comparison of the effects of two dinitroanilines against Cryptosporidium parvum in vitro and in vivo in neonatal mice and rats.
    Armson A; Sargent K; MacDonald LM; Finn MP; Thompson RC; Reynoldson JA
    FEMS Immunol Med Microbiol; 1999 Nov; 26(2):109-13. PubMed ID: 10536296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of oryzalin and associated histological changes in Cryptosporidium-infected neonatal rats.
    Armson A; Menon K; O'Hara A; MacDonald LM; Read CM; Sargent K; Thompson RC; Reynoldson JA
    Parasitology; 2002 Aug; 125(Pt 2):113-7. PubMed ID: 12211604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of dinitroanilines for treatment of cryptosporidiosis.
    Benbow JW; Bernberg EL; Korda A; Mead JR
    Antimicrob Agents Chemother; 1998 Feb; 42(2):339-43. PubMed ID: 9527782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Highly Active AntiRetroviral Therapy and cryptosporidiosis].
    Morales Gomez MA
    Parassitologia; 2004 Jun; 46(1-2):95-9. PubMed ID: 15305695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium: assessment of the antimalarial potential of trifluralin and related compounds using a rat model of malaria, Rattus norvegicus.
    Dow GS; Armson A; Boddy MR; Itenge T; McCarthy D; Parkin JE; Thompson RC; Reynoldson JA
    Exp Parasitol; 2002 Mar; 100(3):155-60. PubMed ID: 12173400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved efficacy of dinitroaniline analogs for use as anti-cryptosporidial drugs.
    Mead JR; Benbow JW; Garmon D; Stewart J
    J Eukaryot Microbiol; 1999; 46(5):62S-63S. PubMed ID: 10519250
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of dinitroaniline herbicides on the growth of Entamoeba histolytica.
    Makioka A; Kumagai M; Ohtomo H; Kobayashi S; Takeuchi T
    J Parasitol; 2000 Jun; 86(3):607-10. PubMed ID: 10864261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activity of decoquinate against Cryptosporidium parvum in cell cultures and neonatal mice.
    Lindsay DS; Woods KM; Upton SJ; Blagburn BL
    Vet Parasitol; 2000 May; 89(4):307-11. PubMed ID: 10799844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpected activity of beta-cyclodextrin against experimental infection by Cryptosporidium parvum.
    Castro-Hermida JA; Freire-Santos F; Oteiza-Löpez AM; Ares-Mazás E
    J Parasitol; 2000 Oct; 86(5):1118-20. PubMed ID: 11128490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of chitosan, a natural polysaccharide, against Cryptosporidium parvum in vitro and in vivo in neonatal mice.
    Mammeri M; Chevillot A; Thomas M; Polack B; Julien C; Marden JP; Auclair E; Vallée I; Adjou KT
    Exp Parasitol; 2018 Nov; 194():1-8. PubMed ID: 30237052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Toxoplasma gondii replication by dinitroaniline herbicides.
    Stokkermans TJ; Schwartzman JD; Keenan K; Morrissette NS; Tilney LG; Roos DS
    Exp Parasitol; 1996 Dec; 84(3):355-70. PubMed ID: 8948325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anthelmintic effect of herbicidal dinitroanilines on the nematode model Caenorhabditis elegans.
    Sant'anna V; de Souza W; Vommaro RC
    Exp Parasitol; 2016 Aug; 167():43-9. PubMed ID: 27118457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment with agmatine inhibits Cryptosporidium parvum infection in infant mice.
    Moore D; Waters WR; Wannemuehler MJ; Harp JA
    J Parasitol; 2001 Feb; 87(1):211-3. PubMed ID: 11227893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of benzimidazoles against cryptosporidiosis in neonatal BALB/c mice.
    Fayer R; Fetterer R
    J Parasitol; 1995 Oct; 81(5):794-5. PubMed ID: 7472880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of cryptosporidium parvum in vitro by 9-(alkylthio)acridine derivatives.
    Khalifa L; Rosales MJ; Mascaro C; Karolak-Wojciechowska J; Bsiri N; Brouant P; Barbe J
    Arzneimittelforschung; 2000 Feb; 50(2):163-6. PubMed ID: 10719621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo efficacy of lasalocid for treatment of experimental cryptosporidiosis.
    Castro Hermida JA; Freire Santos F; Oteiza López AM; Vergara Castiblanco CA; Ares-Mazás ME
    Vet Parasitol; 2000 Jul; 90(4):265-70. PubMed ID: 10856813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of pyrvinium pamoate against Cryptosporidium parvum infection in vitro and in a neonatal mouse model.
    Downey AS; Chong CR; Graczyk TK; Sullivan DJ
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3106-12. PubMed ID: 18591280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dicationic furans inhibit development of Cryptosporidium parvum in HSD/ICR suckling Swiss mice.
    Blagburn BL; Drain KL; Land TM; Moore PH; Kinard RG; Lindsay DS; Kumar A; Shi J; Boykin DW; Tidwell RR
    J Parasitol; 1998 Aug; 84(4):851-6. PubMed ID: 9714224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of particulate drug formulation against C. parvum: Formulation, characterization and in vivo efficacy.
    Blanco-García E; Guerrero-Callejas F; Blanco-Méndez J; Gómez-Couso H; Luzardo-Álvarez A
    Eur J Pharm Sci; 2016 Sep; 92():74-85. PubMed ID: 27381880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapeutic effect of azithromycin and lasalocid on Cryptosporidium infection in mice.
    Kimata I; Uni S; Iseki M
    J Protozool; 1991; 38(6):232S-233S. PubMed ID: 1667931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.